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ABSTRACT
The importance of infections for public health has become obvious during the last decades. Examples are
emerging infections such as HIV ⁄AIDS and severe acute respiratory syndrome, deliberate release of
microorganisms, such as the anthrax episode in the USA, the increasing problems with organisms
resistant to antimicrobial treatment, such as methicillin-resistant Staphylococcus aureus, and the threat of a
new inﬂuenza pandemic with a case fatality rate similar to that in the 1918 outbreak. An effective response
to infectious disease emergencies requires careful planning and establishment of resources in advance.
The medical specialties involved are clinical microbiology, clinical infectious diseases and epidemiology.
Clinical microbiology should include bacteriology, virology and parasitology; the technical developments
during the last 15 years have clearly erased most of the methodological differences between these
branches of microbiology. New techniques such as new generations of Polymerase Chain Reaction (PCR),
rapidmethods for nucleic acid sequence analyses andmicroarrays have enabledmore rapid identiﬁcation
of organisms and provide powerful tools in the epidemiological analysis of an outbreak. The infectious
disease specialists are necessary for rapid and adequate clinical diagnoses, optimal use of antimicrobial
agents and provision of facilities for containment of patients who may spread the infections. The need for
isolation units became acute when many countries prepared themselves for a possible severe acute
respiratory syndrome outbreak in Europe. With few exceptions, Europe still lacks epidemiological ﬁeld
forces, and it has been embarrassing to be obliged to call upon the Centers for Disease Control for
European outbreaks. Hopefully, this will be correctedwith the creation of the European Centre for Disease
Prevention and Control (ECDC).
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INTRODUCTION
Infectious diseases (IDs) have plagued human-
kind during its entire existence. With some
notable exceptions, e.g., tuberculosis and HIV
infections, IDs are acute and short-lasting. They
afﬂict humans of all ages but are more common in
children, the elderly and individuals who are
immunocompromised, a group that is increasing
rapidly, however with improved access to mod-
ern treatment of malignancies and the possibility
of organ transplants.
Although patients with infections are seen by
all physicians, who therefore need basic know-
ledge of how to diagnose and treat them, ID
specialists are needed for optimal handling of
many of these conditions, especially when dealing
with emerging or re-emerging infections or major
outbreaks of IDs. This overview will deal with
some of the roles of an ID specialist, especially
when society is faced with a major epidemic or
increasing frequencies of infections caused by
organisms resistant to antimicrobial drugs.
TRAINING OF ID SPECIALISTS
The training of an ID specialist should provide
detailed knowledge of the clinical presentations
of common IDs. This normally requires basic
training in internal medicine for 2–3 years, to
which should be added training at an ID unit or
department. In addition, the specialist should
have enough experience in clinical microbiology
to know which samples should be taken for rapid
and adequate aetiological diagnosis of an infec-
tion and also how to interpret the reports from the
laboratories. While in most countries the ID
specialist has internal medicine as a basis, there
are other systems:
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• In some countries, e.g., Sweden, the requirement
for training in internal medicine is reduced to
approximately 1 year, with a longer period at an
ID unit, and the specialty is an independent one.
The lack of formal internal medicine training is
to some extent compensated for by the fact that,
in Sweden, ID departments normally care for
patients with respiratory tract infections, hepa-
titis, pyelonephritis or surgical infections.
• Similar to the situation in the USA, some coun-
tries, e.g., Finland, have chosen tomake ID a sub-
specialty of either internal medicine or paediat-
rics. It is notable that inmany countries infections
are included in general paediatrics and are not
considered to require special training.
• In the UK, a new curriculum for training of
specialists in ‘infection’ has recently been intro-
duced. Under this programme, the physicians
receive approximately 3 years of training in
each of the specialties: internal medicine, clin-
ical IDs and clinical microbiology. Although the
training period is longer than normal, it pro-
vides an optimal basis for an ID specialist.
The ID specialty is today recognised in most
European countries, notable exceptions being
Austria, Belgium and Spain. In most countries
the ID physicians serve as consultants and have
relatively few, if any, beds of their own. However,
in some countries, e.g., Sweden, there are relatively
high numbers of beds in ID departments. Advan-
tages of the latter system are that the capacity for
effective isolation of contagious patients is in-
creased and that the staff members have special
training in preventing the spread of infections.
ID EMERGENCIES AND THE ROLE OF
THE ID SPECIALIST
In 1972 the US Surgeon General is claimed to have
said, ‘The book of infectious diseases can now
ultimately be closed.’ Obviously, that statement
was not justiﬁed. Since then the world has seen the
emergence of several important infections. Exam-
ples are acquired immunodeﬁciency syndrome,
hantavirus cardiopulmonary syndrome and severe
acute respiratory syndrome (SARS). In addition,
the rapid development of new microbiological
techniques has made it possible to identify the
aetiology of many important infections, such as
those caused by Legionella pneumophila,Helicobacter
pylori, several new viruses causing infectious
hepatitis, and viruses causing haemorrhagic
fevers. In many cases these discoveries have led
to the development of effective treatments.
The ID specialist has several important roles in
the management of emerging infections. First, and
perhaps most important, is the recognition of a
disease pattern and ⁄ or an epidemiological pattern
outside the normal, i.e., the recognition of an
epidemic. The earlier this is done, the easier it will
be to contain an outbreak. An excellent example is
the SARS epidemic. The ﬁrst wave of some 300
patients with severe respiratory tract infections in
the Guangdong province was noted as an accumu-
lation of cases of atypical pneumonia. It was
dismissed by local authorities and the World
Health Organization (WHO) as not being a new
inﬂuenza outbreak andnot having any connections
with avian inﬂuenza. However, only days after the
worldwide dissemination from the index case at
HotelMetropole inHongKong, it became obvious,
through observation by physicians in Hong Kong
and Hanoi, that this was a completely new ID
outbreak, which required extraordinary actions.
Rapid recognition of the SARS outbreak also made
it possible to contain the infection despite the fact
that it had spread worldwide at an early stage.
In situations such as the SARS epidemic, the ID
specialist has, or should have, clearly deﬁned roles:
• Recognise the fact that a new epidemic has
emerged. This is facilitated by regular ID
consultancies at intensive care units and emer-
gency rooms.
• Initiate cooperation with clinical microbiolo-
gists to achieve optimal sampling to identify the
aetiological agent. This may require access to
special laboratory facilities, such as P3 and P4
laboratories. The latter are available in only a
few countries, and samples may have to be sent
to laboratories abroad.
• Decide (or advise) on isolation of patients and
hygienic measures to avoid transmission of the
infection. This should be done in close cooper-
ation with cross-infection control specialists.
• Advise public health authorities on measures to
be taken to limit the extent and consequences of
an epidemic.
• Assist public health authorities in communica-
tions with news media and the general public.
It is obvious that IDspecialists cannot andshould
not operate as solitary individuals or groups of
specialists. Optimal handling of outbreaks requires
building of networks within healthcare and public
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health agencies. Key actors at the local level, in
addition to the ID specialists, are the clinical
microbiologists, hospital hygiene specialists, epi-
demiologists and public health organisations.
When an epidemic results in large numbers of
patients requiring hospital care, the local hospital
authorities will have an important role to play. On
the national level, most countries have infection
control agencies,which, as early aspossible, should
be informed about suspected outbreaks. Interna-
tionally, the European Union network for surveil-
lance of IDs should be contacted, as should the
WHO. These contacts should be made through the
national infection control agency. On a European
level, it is likely that in the future the coordinating
role within Europe will be taken over by the Euro-
pean Centre for Disease Prevention and Control.
ANTIMICROBIAL RESISTANCE
A major reason why the Surgeon General was
wrong was that he had not foreseen the problem
of antimicrobial resistance. Today, such resistance
is creating problems with handling a broad range
of infections. In most countries, antibiotic
resistance is very common in staphylococci,
enterococci, pneumococci, enterobacters and
non-fermenting Gram-negative species such as
Pseudomonas spp. and Acinetobacter spp. In Myco-
bacterium tuberculosis, resistance to one of the main
agents (rifampicin and isoniazid) is common and
the frequency of multiresistant strains is increas-
ing. Resistance is also creating clinical problems
in viral infections. This is most pronounced for
anti-retroviral drugs, and primary resistance, i.e.,
resistance to one or more anti-HIV drugs at the
time of acquisition of the infection, is not uncom-
mon. In parasitology, resistance to anti-malarial
drugs is an increasing problem, which has led to a
recommendation to use combination therapy for
prophylaxis and treatment, something that is
often not affordable in developing countries.
Adding to the problems of antimicrobial resist-
ance is the fact that the development of new drugs
for treatment of infections caused by resistant
organisms is slowing down. At present, only ﬁve
new antibiotics are in clinical development, and
none of them will increase the possibilities of
treating infections caused by multiresistant Gram-
negative bacteria [1].
The ID specialist has several important roles in
combating antibiotic resistance. By education of
colleagues and the general public, improper use of
antibiotics should be avoided or reduced. It seems
clear that in most countries there is a marked
overuse of antibiotics [2]. Proper sampling from
patients with infections should facilitate identiﬁ-
cation of resistant organisms. When infections
caused by resistant organisms occur in a hospital
setting, the ID specialists, together with the hos-
pital hygiene specialists, should initiate necessary
measures to avoid dissemination. In this respect, it
is important to remember that more and more
elderly people with serious conditions are cared
for outside of hospitals, in nursing homes or even
in their own homes. It is not unusual for these
patients to harbour resistant bacteria as a result of
more or less indiscriminate use of antibiotics.
Again, the best way to reduce the consequences of
such resistance is to increase the sampling for
microbiological investigations, so that, when such
a patient is hospitalised, adequate isolation and
hygienic measures can be taken.
CONCLUSIONS
The ID specialty should be seen as an essential
component inmodern healthcare. Themoney used
to create an effective ID service is well-invested,
since ID specialists will decrease the risk of dis-
semination of infections within hospitals and
within society. Also, by optimising antibiotic treat-
ment, in terms of choice of drugs, dosages and
treatment times, these specialists can contribute to
a reduction in the incidence of antimicrobial
resistance, the consumption of such medicines
and the risk of nosocomial infections caused by
resistant bacteria.
To be optimally efﬁcient, the ID specialist must
work in close cooperation with clinical microbiol-
ogists and hospital hygiene specialists. When
outbreaks occur, cooperation with public health
organisations is also necessary, as well as with
national infection control agencies and with inter-
national organisations suchas theEuropeanCentre
for Disease Prevention and Control and the WHO.
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